Zerigo Health

Zerigo Health is a biopharma startup founded in 2014 that offers a smart, convenient, and cost-effective solution for treating chronic skin conditions such as eczema and psoriasis. The company's slogan "A smarter, no-cost solution for your employees living with chronic autoimmune skin conditions" emphasizes its commitment to providing innovative healthcare options for individuals with these conditions. With its focus on Biopharma, Biotechnology, and Health Care industries, Zerigo Health has garnered significant attention from investors, with its last investment amounting to a substantial $43.00M in a Series B funding round on 21 October 2021. Noteworthy investors involved in this round include 7Wire Ventures, SV Health Investors, General Catalyst, Bluestem Capital, Cigna Ventures, Dragoneer Investment Group, Leaps by Bayer, H.I.G. Capital, and Leverage Health. Zerigo Health's ability to attract such a diverse and reputable group of investors demonstrates its potential for disruptive innovation within the healthcare sector. With its headquarters in the United States, Zerigo Health stands at the intersection of technology and healthcare, offering promising solutions that have the potential to positively impact both patients and the broader healthcare ecosystem.